1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Diagnostic Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 S100
  • 1.2.3 MART-1
  • 1.2.4 Gp100
  • 1.2.5 HMB45
  • 1.2.6 AFP
  • 1.2.7 BCR-ABL
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Diagnostic Biomarker Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Cancer Research Institutes
  • 1.3.4 Diagnostic Labs
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Diagnostic Biomarker Market Perspective (2015-2026)
• 2.2 Global Diagnostic Biomarker Growth Trends by Regions
  • 2.2.1 Diagnostic Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Diagnostic Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Diagnostic Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Diagnostic Biomarker Players by Market Size
  • 3.1.1 Global Top Diagnostic Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2015-2020)
• 3.2 Global Diagnostic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Diagnostic Biomarker Revenue
• 3.4 Global Diagnostic Biomarker Market Concentration Ratio
  • 3.4.1 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarker Revenue in 2019
• 3.5 Key Players Diagnostic Biomarker Area Served
• 3.6 Key Players Diagnostic Biomarker Product Solution and Service
• 3.7 Date of Enter into Diagnostic Biomarker Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Biomarker Breakdown Data by Type (2015-2026)

• 4.1 Global Diagnostic Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Diagnostic Biomarker Forecasted Market Size by Type (2021-2026)

5 Diagnostic Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Diagnostic Biomarker Historic Market Size by Application (2015-2020)
• 5.2 Global Diagnostic Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Diagnostic Biomarker Market Size (2015-2026)
• 6.2 North America Diagnostic Biomarker Market Size by Type (2015-2020)
• 6.3 North America Diagnostic Biomarker Market Size by Application (2015-2020)
• 6.4 North America Diagnostic Biomarker Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Diagnostic Biomarker Market Size (2015-2026)
• 7.2 Europe Diagnostic Biomarker Market Size by Type (2015-2020)
• 7.3 Europe Diagnostic Biomarker Market Size by Application (2015-2020)
• 7.4 Europe Diagnostic Biomarker Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Diagnostic Biomarker Market Size (2015-2026)
• 8.2 China Diagnostic Biomarker Market Size by Type (2015-2020)
• 8.3 China Diagnostic Biomarker Market Size by Application (2015-2020)
• 8.4 China Diagnostic Biomarker Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Diagnostic Biomarker Market Size (2015-2026)
• 9.2 Japan Diagnostic Biomarker Market Size by Type (2015-2020)
• 9.3 Japan Diagnostic Biomarker Market Size by Application (2015-2020)
• 9.4 Japan Diagnostic Biomarker Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Diagnostic Biomarker Market Size (2015-2026)
• 10.2 Southeast Asia Diagnostic Biomarker Market Size by Type (2015-2020)
• 10.3 Southeast Asia Diagnostic Biomarker Market Size by Application (2015-2020)
• 10.4 Southeast Asia Diagnostic Biomarker Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Biocrates Life Sciences
  • 11.1.1 Biocrates Life Sciences Company Details
  • 11.1.2 Biocrates Life Sciences Business Overview
  • 11.1.3 Biocrates Life Sciences Diagnostic Biomarker Introduction
  • 11.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020))
  • 11.1.5 Biocrates Life Sciences Recent Development
• 11.2 Augurex Life Sciences
  • 11.2.1 Augurex Life Sciences Company Details
  • 11.2.2 Augurex Life Sciences Business Overview
  • 11.2.3 Augurex Life Sciences Diagnostic Biomarker Introduction
  • 11.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.2.5 Augurex Life Sciences Recent Development
• 11.3 Biomedical
  • 11.3.1 Biomedical Company Details
  • 11.3.2 Biomedical Business Overview
  • 11.3.3 Biomedical Diagnostic Biomarker Introduction
  • 11.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.3.5 Biomedical Recent Development
• 11.4 Target Discovery
  • 11.4.1 Target Discovery Company Details
  • 11.4.2 Target Discovery Business Overview
  • 11.4.3 Target Discovery Diagnostic Biomarker Introduction
  • 11.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.4.5 Target Discovery Recent Development
• 11.5 Banyan Biomarkers
  • 11.5.1 Banyan Biomarkers Company Details
  • 11.5.2 Banyan Biomarkers Business Overview
  • 11.5.3 Banyan Biomarkers Diagnostic Biomarker Introduction
  • 11.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.5.5 Banyan Biomarkers Recent Development
• 11.6 Astute Medical
  • 11.6.1 Astute Medical Company Details
  • 11.6.2 Astute Medical Business Overview
  • 11.6.3 Astute Medical Diagnostic Biomarker Introduction
  • 11.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.6.5 Astute Medical Recent Development
• 11.7 Axela
  • 11.7.1 Axela Company Details
  • 11.7.2 Axela Business Overview
  • 11.7.3 Axela Diagnostic Biomarker Introduction
  • 11.7.4 Axela Revenue in Diagnostic Biomarker Business (2015-2020)
  • 11.7.5 Axela Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Diagnostic Biomarker Scope and Market Size
Diagnostic Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others

Market segment by Application, split into
Hospitals
Cancer Research Institutes
Diagnostic Labs

Based on regional and country-level analysis, the Diagnostic Biomarker market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Diagnostic Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela
...